论文信息 - CARSKIN: Pembrolizumab as first line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC). - 字舞流文

CARSKIN: Pembrolizumab as first line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC).

M. Boubaya | O. Schischmanoff | V. Lévy | E. Maubec | L. Deschamps | Isabelle Scheer-Senyarich | S. Helfen | A. Tibi | C. Alloux | I. Lopez | P. Petrow